Market Research

COVID-19 Impact Analysis on Blood Screening Market. Insights on Strategies of Key Players

Jun 23, 2020 9:10 PM ET

iCrowd Newswire – Jun 23, 2020

The prevalence of various diseases across the globe is rising on a rapid pace. While some mild infections or diseases can be treated by taking proper medication, severe cases often create need for operations and surgeries. Such cases, among many serious cases including injuries, sometimes require blood transfusion. The awareness regarding blood donation has risen considerably, which is why numerous people donate blood, at times, regularly. It is now news that blood transfusion is a serious matter and medical professionals need to take utmost care before and during carrying of such a procedure.

Request to view sample of this market research:

Owing to the surging prevalence of diseases, the blood screening market generated a revenue of $2,402.3 million in 2019, and it is projected to advance at an 8.1% CAGR during the forecast period by P&S Intelligence. Different types of products that are utilized during the blood screening process are software and services, reagents and kits, and instruments. Out of these, the largest demand in the years to come is expected to be created for reagents and kits, as these products are utilized during the very first stage of the blood screening process. These products are used extensively for effective and quick detection of transfusion-transmissible diseases.

Geographically, North America emerged as the largest blood screening market in 2019, which is attributed to the surging incidence of infectious and respiratory diseases in the region. For example, the region has accounted for the largest number of COVID-19 cases and deaths, i.e. 560,000and 22,000, respectively, as of April 13th 2020. Other than this, the demand for blood screening is also predicted to rise considerable in the Asia-Pacific region in the near future. This is due to the presence of major players, rising incidence of cancer and other chronic diseases, and cost-effective labor.

Pre-Purchase Inquiry at:

The key players in the global blood screening market are Bio-Rad Laboratories Inc., Abbott Laboratories, General Electric Company, Becton, Dickinson and Company, Merck KGaA, Thermo Fisher Scientific Inc., Grifols S.A., Siemens AG, DiaSorin S.p.A, Ortho-Clinical Diagnostics Inc., Bio-Techne Corporation, J. Mitra & Co. Pvt. Ltd., Gesellschaft zur Forschung, Trinity Biotech plc, F. Hoffmann-La Roche Ltd., Entwicklung und Distribution von Diagnostika im Blutspendewesen mbH (GFE), PerkinElmer Inc., Danaher Corporation, and bioMérieux SA.

The research includes detailed analysis of;

By Product Type

  • Reagents and Kits
    • Nucleic acid technology (NAT)
      • Enzymes and polymerases
      • Standards and controls
      • Buffers, nucleotides, and solutions
      • Probes and primers
      • Labeling and detection reagents
    • Enzyme-linked immunosorbent assay (ELISA)
      • Immunosorbents
      • Controls
      • Conjugates
      • Substrates
      • Sample diluents and wash solutions
  • Instruments
    • By platform
      • Automated
      • Semi-automated
    • By purchase type
      • Rental
      • Outright
  • Software & Services

By Technology

  • NAT
  • Rapid Testing
  • Western Blotting
  • Next-Generation Sequencing (NGS)

By Disease Type

  • Human Immunodeficiency Virus/Acquired-Immuno Deficiency Syndrome (HIV/AIDS)
  • Cancer
  • Diabetes Mellitus
  • Infectious Diseases
  • Hypercholesterolemia
  • Respiratory Diseases

By End User

  • Blood Banks
  • Diagnostic Centers and Pathology Labs
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers (ASCs)

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact Information:

P&S Intelligence
International: +1-347-960-6455
Email: [email protected]


Keywords:    Blood Screening Market, COVID 19 Impact of Blood Screening, Blood Screening Industry